Eurofins Scientific SE Asset Resilience Ratio
Eurofins Scientific SE asset resilience ratio. Eurofins Scientific SE (ERF) has an Asset Resilience Ratio of 7.20% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Eurofins Scientific SE to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Eurofins Scientific SE (2004–2025)
Asset resilience ratio of Eurofins Scientific SE from 2004 to 2025. This chart shows how Eurofins Scientific SE's Asset Resilience Ratio has changed over time. Read ERF total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Eurofins Scientific SE's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Eurofins Scientific SE asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €791.00 Million | 7.2% |
| Short-term Investments | €0.00 | 0% |
| Total Liquid Assets | €791.00 Million | 7.20% |
Asset Resilience Insights
- Limited Liquidity: Eurofins Scientific SE maintains only 7.20% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Eurofins Scientific SE Industry Peers by Asset Resilience Ratio
Compare Eurofins Scientific SE's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY |
Diagnostics & Research | 0.00% |
|
Wuhan Thalys Med Tech Co Ltd
SHG:603716 |
Diagnostics & Research | 0.16% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193 |
Diagnostics & Research | 70.50% |
|
Krsnaa Diagnostics Limited
NSE:KRSNAA |
Diagnostics & Research | 9.90% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
Eurofins Scientific SE Asset Resilience Ratio by Year (2004–2025)
Eurofins Scientific SE asset resilience ratio by year from 2004 to 2025. The table below shows the annual Asset Resilience Ratio data for Eurofins Scientific SE.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 2.29% | €251.60 Million ≈ $294.15 Million |
€10.98 Billion ≈ $12.84 Billion |
+1.53pp |
| 2024-12-31 | 0.77% | €83.30 Million ≈ $97.39 Million |
€10.89 Billion ≈ $12.73 Billion |
-3.61pp |
| 2023-12-31 | 4.38% | €476.40 Million ≈ $556.96 Million |
€10.89 Billion ≈ $12.73 Billion |
+3.30pp |
| 2022-12-31 | 1.08% | €108.80 Million ≈ $127.20 Million |
€10.08 Billion ≈ $11.79 Billion |
+0.71pp |
| 2021-12-31 | 0.37% | €34.80 Million ≈ $40.68 Million |
€9.33 Billion ≈ $10.91 Billion |
+0.17pp |
| 2020-12-31 | 0.20% | €17.40 Million ≈ $20.34 Million |
€8.58 Billion ≈ $10.03 Billion |
+0.16pp |
| 2019-12-31 | 0.05% | €3.60 Million ≈ $4.21 Million |
€7.82 Billion ≈ $9.15 Billion |
-0.30pp |
| 2018-12-31 | 0.34% | €24.60 Million ≈ $28.76 Million |
€7.21 Billion ≈ $8.42 Billion |
-2.29pp |
| 2017-12-31 | 2.63% | €153.29 Million ≈ $179.22 Million |
€5.83 Billion ≈ $6.82 Billion |
-9.63pp |
| 2016-12-31 | 12.25% | €506.02 Million ≈ $591.59 Million |
€4.13 Billion ≈ $4.83 Billion |
-3.72pp |
| 2015-12-31 | 15.98% | €591.10 Million ≈ $691.06 Million |
€3.70 Billion ≈ $4.33 Billion |
+12.04pp |
| 2014-12-31 | 3.94% | €73.83 Million ≈ $86.31 Million |
€1.87 Billion ≈ $2.19 Billion |
-8.19pp |
| 2013-12-31 | 12.13% | €181.62 Million ≈ $212.34 Million |
€1.50 Billion ≈ $1.75 Billion |
+11.18pp |
| 2012-12-31 | 0.95% | €11.02 Million ≈ $12.88 Million |
€1.16 Billion ≈ $1.36 Billion |
+2.04pp |
| 2007-12-31 | -1.09% | €-6.67 Million ≈ $-7.80 Million |
€612.02 Million ≈ $715.52 Million |
+0.20pp |
| 2006-12-31 | -1.29% | €-5.93 Million ≈ $-6.94 Million |
€460.34 Million ≈ $538.18 Million |
-1.10pp |
| 2004-12-31 | -0.18% | €-351.00K ≈ $-410.36K |
€190.12 Million ≈ $222.28 Million |
-- |
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more